Newly Formed Sports Medicine Division Taps Experienced Leader to Build Elite Athlete Network and Distribution Channel
MEQUON, Wis., June 8, 2026 /CNW/ -- Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the appointment of Darryl Drake Jr. as President of Valor and Chairman of the Athletic Board of Directors. Valor is a newly formed division of Vector, focused on developing relationships in the professional and elite athlete market and building the commercial infrastructure to support Vector's advancing transdermal peptide delivery platform.
k5:G 4=2DDlQ!#}0x>365565pDD6E#676C6?46Q :5lQs:GpDD6E!=246w@=56C`QmkAmk:>8 DC4lQ9EEADi^^>>I]AC?6HDH:C6]4@>^>65:2^|$`fb`ghd^'64E@C0$4:6?46D0%96C2A6FE:4D0{@8@];A8n:5l~paeh_ahdQ E:E=6lQ9EEADi^^G64E@CD4:6?46]4@^Q 2=ElQ9EEADi^^G64E@CD4:6?46]4@^Q ^mk^Amk^5:Gm
kAmsC2<6 H:== =625 '2=@CVD >2C<6E 56G6=@A>6?E 677@CED[ :?:E:2==J AC@>@E:?8 '64E@CVD =:?6 @7 A92C>246FE:42=\8C256 A6AE:56D[ >2?F724EFC65 F?56C 4v|! DE2?52C5D :? 2? usp\=:46?D65 724:=:EJ 2?5 E6DE65 E@ E96 9:896DE DE2?52C5D 7@C D276EJ 2?5 AFC:EJ[ H9:=6 6DE23=:D9:?8 2 ?6EH@C< @7 DA@CED >65:4:?6 4=:?:4:2?D[ EC2:?6CD[ 2?5 6=:E6 2E9=6E6 25G@42E6D 29625 @7 E96 '2=@C EC2?D56C>2= 56=:G6CJ A=2E7@C>VD 4@>>6C4:2= =2F?49] sC2<6 3C:?8D >@C6 E92? 2 564256 @7 =6256CD9:A 3F:=5:?8 9:89\A6C7@C>2?46 4@>>6C4:2= E62>D 24C@DD >F=E:A=6 4@F?EC:6D[ H:E9 2 EC24< C64@C5 @7 >2?28:?8 C6=2E:@?D9:AD H:E9 E@A 2E9=6E6 :?7=F6?46CD 2?5 >F=E:>65:2\5C:G6? A=2E7@C>D E92E A@D:E:@?D 9:> H6== 7@C E96 C6=2E:@?D9:A\7:CDE >2?52E6 '2=@C C6BF:C6D]k^Am
kAm'2=@CVD :?:E:2= 4@>>6C4:2= 7@4FD :D '64E@CVD =:?6 @7 A92C>246FE:42=\8C256 A6AE:56D[ >2?F724EFC65 F?56C 4v|! DE2?52C5D :? 2? usp\=:46?D65[ DE2E6\@7\E96\2CE 724:=:EJ :? |6BF@?[ (:D4@?D:?[ 2?5 E6DE65 E@ E96 9:896DE DE2?52C5D 7@C D276EJ[ AFC:EJ[ 2?5 A@E6?4J] %96 5:G:D:@? :D 56D:8?65 E@ :?E68C2E6 '64E@CVD 25G2?46D :? A6AE:56 D4:6?46 H:E9 :ED 56=:G6CJ A=2E7@C>D[ 4C62E:?8 2 4@>3:?65 2AAC@249 E@ E:DDF6 C6A2:C[ C64@G6CJ[ 2?5 A2:? >:E:82E:@? E92E 8:G6D 4=:?:4:2?D 2?5 2E9=6E6D 2? 2=E6C?2E:G6 E@ DJDE6>:4 A2:? >65:4:?6D[ :?4=F5:?8 @A:2E6D]k^Am
kAmsC2<6 <?@HD 7:CDE92?5 H92E :?256BF2E6 C64@G6CJ @AE:@?D =@@< =:<6 2?5 H92E :E 4@DED 2E9=6E6D H96? A2:? :D >2?2865 H:E9 DJDE6>:4 >65:42E:@?D C2E96C E92? E2C86E65[ D:E6\5:C64E65 :?E6CG6?E:@?] %92E A6CDA64E:G6[ 4@>3:?65 H:E9 9:D 4@>>6C4:2= EC24< C64@C5 2?5 C6=2E:@?D9:AD 24C@DD E96 2E9=6E:4 4@>>F?:EJ[ >256 9:> E96 C:89E 49@:46 E@ =625 '2=@CVD >2C<6E 6?ECJ]k^Am
kA 4=2DDlQAC?>=c_Qmk6>mQpE9=6E6D 56D6CG6 36EE6C E92? DJDE6>:4 A2:? >2?286>6?E 2?5 6IE6?565 C64@G6CJ E:>6=:?6D] '2=@C 6I:DED E@ 492?86 E92E[ H:E9 AC64:D:@? 56=:G6CJ[ E2C86E65 E:DDF6 C6A2:C[ 2?5 D@=FE:@?D 3F:=E 7@C E96 H2J 2E9=6E6D 24EF2==J 962=]Qk^6>mk^Am
kA 4=2DDlQAC?>=c_QmkDEC@?8m\\ s2CCJ= sC2<6 yC][ !C6D:56?E[ '2=@Ck^DEC@?8mk^Am
More from this section
kA 4=2DDlQAC?>=c_Qmk6>mQs2CCJ= 92D E96 C6=2E:@?D9:AD[ E96 EC24< C64@C5[ 2?5 E96 A6CD@?2= 4@?G:4E:@? E9:D C@=6 56>2?5D] w6 :D E96 C:89E A6CD@? E@ E2<6 '2=@C E@ >2C<6E]Qk^6>mk^Am
kA 4=2DDlQAC?>=c_QmkDEC@?8m\\ q:== y24<D@?[ rt~[ '64E@C $4:6?46 U2>Aj %96C2A6FE:4D r@CA]k^DEC@?8mk^Am
kAmkDEC@?8mp3@FE s2CCJ= sC2<6 yC]ik^DEC@?8m p? 62C=J :?G6DE@C :? '64E@C[ sC2<6 92D DA6?E @G6C 2 564256 3F:=5:?8 9:89\A6C7@C>2?46 4@>>6C4:2= E62>D C6DA@?D:3=6 7@C >@C6 E92? S`d_ >:==:@? :? D2=6D 24C@DD >F=E:A=6 4@F?EC:6D[ 4@?D:DE6?E=J C2?<:?8 :? E96 E@A `T @7 6G6CJ @C82?:K2E:@? 96 92D 366? A2CE @7]k^Am
kAmkDEC@?8mp3@FE '2=@Cik^DEC@?8m '2=@C[ E96 DA@CED >65:4:?6 5:G:D:@? @7 '64E@C $4:6?46 U2>Aj %96C2A6FE:4D r@CA] W%$)'i !px}X[ :D AFCA@D6\3F:=E E@ 56G6=@A C6=2E:@?D9:AD :? E96 AC@76DD:@?2= 2E9=6E6 >2C<6E 2?5 3F:=5 E96 5:DEC:3FE:@? 492??6= 7@C '64E@CVD EC2?D56C>2= A6AE:56 56=:G6CJ A=2E7@C>] '2=@CVD 2AAC@249 E2C86ED E:DDF6 C6A2:C[ 2446=6C2E65 C64@G6CJ[ 2?5 D:E6\5:C64E65 A2:? >:E:82E:@?[ 5C2H:?8 @? '64E@CVD A92C>246FE:42=\8C256 A6AE:56 A@CE7@=:@ 2?5 4v|! >2?F724EFC:?8 42A23:=:E:6D :? |6BF@?[ (:D4@?D:?]k^Am
kAmkDEC@?8mp3@FE '64E@C $4:6?46 U2>Aj %96C2A6FE:4D r@CA]ik^DEC@?8m '64E@C $4:6?46 U2>Aj %96C2A6FE:4D[ x?4][ 9625BF2CE6C65 :? |6BF@?[ (:D4@?D:?[ 56G6=@AD ?@G6= 3:@>6492?:42= 56G:46D 2?5 24E:G6 =@42=:K65 5CF8 56=:G6CJ A=2E7@C>D E@ 6BF:A 4=:?:4:2?D H:E9 D:E6\5:C64E65 :?E6CG6?E:@?D H96C6 AC64:D:@? >2EE6CD 2?5 DJDE6>:4 C:D<D 2C6 F?2446AE23=6] %96 r@>A2?JVD D92C6D 2C6 =:DE65 @? E96 %$) '6?EFC6 tI492?86 F?56C E96 DJ>3@= !px}] u@C >@C6 :?7@C>2E:@?[ G:D:E k2 9C67lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^=:?<^nEl_U2>Aj=l6?U2>Aj@lcf_dhff\`U2>Aj9lafhcedaeghU2>AjFl9EEADTbpTauTauHHH]G64E@CD4:6?46]4@TauU2>Aj2lHHH]G64E@CD4:6?46]4@Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHHH]G64E@CD4:6?46]4@k^2m]k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?l{pffhchU2>AjD5la_ae\_e\_gQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^G64E@C\D4:6?46\\E96C2A6FE:4D\2AA@:?ED\52CCJ=\5C2<6\;C\2D\AC6D:56?E\@7\G2=@C\b_afhbha_]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^G64E@C\D4:6?46\\E96C2A6FE:4D\2AA@:?ED\52CCJ=\5C2<6\;C\2D\AC6D:56?E\@7\G2=@C\b_afhbha_]9E>=k^2mk^Am
kAm$~&#rt '64E@C $4:6?46D U2>Aj %96C2A6FE:4Dk^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]?6HDH:C6]42^CE]8:7n}6HDxE6>x5lrbbghU2>Aj%C2?D>:DD:@?0x5la_ae_e_g_fd_rp}psp}(rp}psp!#0rbbghU2>Ajs2E6x5la_ae_e_gQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
